238 related articles for article (PubMed ID: 19914603)
1. Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia.
Han MH; Renthal W; Ring RH; Rahman Z; Psifogeorgou K; Howland D; Birnbaum S; Young K; Neve R; Nestler EJ; Zachariou V
Biol Psychiatry; 2010 Apr; 67(8):761-9. PubMed ID: 19914603
[TBL] [Abstract][Full Text] [Related]
2. Regulator of G-Protein Signaling 4 (RGS4) Controls Morphine Reward by Glutamate Receptor Activation in the Nucleus Accumbens of Mouse Brain.
Kim J; Lee S; Kang S; Jeon TI; Kang MJ; Lee TH; Kim YS; Kim KS; Im HI; Moon C
Mol Cells; 2018 May; 41(5):454-464. PubMed ID: 29754475
[TBL] [Abstract][Full Text] [Related]
3. Regulator of G-Protein Signaling 7 Regulates Reward Behavior by Controlling Opioid Signaling in the Striatum.
Sutton LP; Ostrovskaya O; Dao M; Xie K; Orlandi C; Smith R; Wee S; Martemyanov KA
Biol Psychiatry; 2016 Aug; 80(3):235-45. PubMed ID: 26364547
[TBL] [Abstract][Full Text] [Related]
4. Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine.
Gaspari S; Papachatzaki MM; Koo JW; Carr FB; Tsimpanouli ME; Stergiou E; Bagot RC; Ferguson D; Mouzon E; Chakravarty S; Deisseroth K; Lobo MK; Zachariou V
Neuropsychopharmacology; 2014 Jul; 39(8):1968-77. PubMed ID: 24561386
[TBL] [Abstract][Full Text] [Related]
5. A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.
Psifogeorgou K; Terzi D; Papachatzaki MM; Varidaki A; Ferguson D; Gold SJ; Zachariou V
J Neurosci; 2011 Apr; 31(15):5617-24. PubMed ID: 21490202
[TBL] [Abstract][Full Text] [Related]
6. Splicing factor transformer-2β (Tra2β) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine.
Li SJ; Li Y; Cui SC; Qi Y; Zhao JJ; Liu XY; Xu P; Chen XH
PLoS One; 2013; 8(8):e72220. PubMed ID: 23977258
[TBL] [Abstract][Full Text] [Related]
7. Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models.
Stratinaki M; Varidaki A; Mitsi V; Ghose S; Magida J; Dias C; Russo SJ; Vialou V; Caldarone BJ; Tamminga CA; Nestler EJ; Zachariou V
Proc Natl Acad Sci U S A; 2013 May; 110(20):8254-9. PubMed ID: 23630294
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal RGS4 inhibitor, CCG50014, reduces nociceptive responses and enhances opioid-mediated analgesic effects in the mouse formalin test.
Yoon SY; Woo J; Park JO; Choi EJ; Shin HS; Roh DH; Kim KS
Anesth Analg; 2015 Mar; 120(3):671-677. PubMed ID: 25695583
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.
Wang Q; Liu-Chen LY; Traynor JR
J Biol Chem; 2009 Jul; 284(27):18357-67. PubMed ID: 19416973
[TBL] [Abstract][Full Text] [Related]
10. RGSZ1 and GAIP regulate mu- but not delta-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance.
Garzón J; Rodríguez-Muñoz M; López-Fando A; García-España A; Sánchez-Blázquez P
Neuropsychopharmacology; 2004 Jun; 29(6):1091-104. PubMed ID: 14997173
[TBL] [Abstract][Full Text] [Related]
11. The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins.
Garzón J; Rodríguez-Muñoz M; López-Fando A; Sánchez-Blázquez P
Neuropsychopharmacology; 2005 Sep; 30(9):1632-48. PubMed ID: 15827571
[TBL] [Abstract][Full Text] [Related]
12. Essential role for RGS9 in opiate action.
Zachariou V; Georgescu D; Sanchez N; Rahman Z; DiLeone R; Berton O; Neve RL; Sim-Selley LJ; Selley DE; Gold SJ; Nestler EJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13656-61. PubMed ID: 14595021
[TBL] [Abstract][Full Text] [Related]
13. Reflections on: "A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function".
Nestler EJ
Brain Res; 2016 Aug; 1645():71-4. PubMed ID: 26740398
[TBL] [Abstract][Full Text] [Related]
14. Regulation of RGS proteins by chronic morphine in rat locus coeruleus.
Gold SJ; Han MH; Herman AE; Ni YG; Pudiak CM; Aghajanian GK; Liu RJ; Potts BW; Mumby SM; Nestler EJ
Eur J Neurosci; 2003 Mar; 17(5):971-80. PubMed ID: 12653973
[TBL] [Abstract][Full Text] [Related]
15. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.
Glück L; Loktev A; Moulédous L; Mollereau C; Law PY; Schulz S
Biol Psychiatry; 2014 Nov; 76(10):767-74. PubMed ID: 24629717
[TBL] [Abstract][Full Text] [Related]
16. R7BP modulates opiate analgesia and tolerance but not withdrawal.
Terzi D; Cao Y; Agrimaki I; Martemyanov KA; Zachariou V
Neuropsychopharmacology; 2012 Mar; 37(4):1005-12. PubMed ID: 22089315
[TBL] [Abstract][Full Text] [Related]
17. Galanin protects against behavioral and neurochemical correlates of opiate reward.
Hawes JJ; Brunzell DH; Narasimhaiah R; Langel U; Wynick D; Picciotto MR
Neuropsychopharmacology; 2008 Jul; 33(8):1864-73. PubMed ID: 17957220
[TBL] [Abstract][Full Text] [Related]
18. RGS9 proteins facilitate acute tolerance to mu-opioid effects.
Garzón J; Rodríguez-Díaz M; López-Fando A; Sánchez-Blázquez P
Eur J Neurosci; 2001 Feb; 13(4):801-11. PubMed ID: 11207815
[TBL] [Abstract][Full Text] [Related]
19. RGS9-2 is a negative modulator of mu-opioid receptor function.
Psifogeorgou K; Papakosta P; Russo SJ; Neve RL; Kardassis D; Gold SJ; Zachariou V
J Neurochem; 2007 Oct; 103(2):617-25. PubMed ID: 17725581
[TBL] [Abstract][Full Text] [Related]
20. A role of RGS proteins in drug addiction.
Hooks SB; Martemyanov K; Zachariou V
Biochem Pharmacol; 2008 Jan; 75(1):76-84. PubMed ID: 17880927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
